Report Categories
View AllRecent Articles
View All
What News Is Impacting Zedge Zdge Stock Price At 2.89 Down 1.37 20260402
Is Intrusion INTZ stock safe today Q4 2025 Below Expectations
Lindsay Corporation LNN Stock Forecast Lindsay Corporation misses EPS estimates by 324
ACH Accendra Health Inc shares climb almost six percent despite a narrow Q4 2025 earnings per share miss
Airbnb Expands Beyond Core Rentals with AI Planning Airport Transfers and World Cup Experiences
USIran Military Exchanges Escalate for Second Time in Days Raising Geopolitical Risks
Robinhood Launches AI Agents for Automated Trading and Credit Card Spending
Music Catalogs Attract Institutional Capital as SonyGIC Joint Venture Acquires Recognition Music Group for 4 Billion
Singapore Core Inflation Drops Unexpectedly in April Future Cost Pressures Remain
Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends
CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6
WaFd Inc WAFD Q1 2026 Earnings Strong EPS Beat Drives Confidence Amid Steady Performance
PANL Q1 2026 Earnings EPS Beats Estimates Amidst Market Skepticism
AIRG Q1 2026 Earnings EPS Miss Slightly but Shares Rise on Operational Highlights
YB Q2 2025 Earnings EPS of 092 Drives DoubleDigit Stock Rally
BA Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside
Select Medical Holdings SEM Holds Steady Near Key Support After Modest Uptick
Fathom Holdings FTHM Slides 7 as Stock Tests Key Support Near 056
FACT II Acquisition Corp Warrant FACTW Slides 37 as Warrants Approach Key Support
UTStarcom Holdings UTSI Surges 575 as Shares Test Key Resistance at 298
Scinai Immunotherapeutics SCNI Holds Near Support After Modest Decline
Plug Power PLUG Edges Up 2 as Hydrogen Momentum Builds
KimberlyClark KMB Edges Higher 178 as Defensive Appeal Strengthens
Lakeshore Acquisition III Corp Rights LCCCR Holds Steady at 024 Amid Limited Activity
Rackspace Technology RXT Declines Over 6 as Selling Pressure Intensifies
Sunrise Realty Trust SUNS Slips 08 as Support Levels Come Into Focus
Allogene Therapeutics ALLO Surges 755 as Biotech Momentum Builds